Evaluation of the effect of normalization of prime sodium with patientsâ€™ blood and its effect on Delirium occurrence in patients undergoing cardiopulmonary by pass

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20191229001

Enrollment

Unknown

Registered

2019-12-29

Start date

2018-12-29

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing cardiopulmonary by pass prime sodiu&#44

Interventions

sodium primer ,no intervention

Active Comparator Drug,No Intervention No treatment

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: patients undergoing cardiopulmonary by pass

Exclusion criteria

Exclusion criteria: Addicted patients patients with psychiatric disorders, Brain lesions ,epilepsy and Kidney Failure

Design outcomes

Primary

Measure	Time frame
sodium blood level before and after the surgery by lab test	—

Secondary

Measure	Time frame
side effects after the surgery monitoring	—

Countries

Iran

Contacts

Public Contactyousef mosania

shahid sadoughi university of medical sciences

jra@ssu.ac.ir00983537240171

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026